Navigating Pain Management: The Role of Buprenorphine and Methadone Amidst the Opioid Crisis

The Role of Buprenorphine and Methadone Amidst the Opioid Crisis

Learners will take away systematic approaches to acute and chronic pain management for people with a history of sub-stance use disorder. This will include being able to summarize the evidence base for buprenorphine for the treatment of chronic pain (in the absence of opioid use disorder), the reasons for and steps to transition a patient from high dose opioids to buprenorphine, and how to have clinical conversations about this transition. The role of methadone in this population will also be covered. The expert faculty will also explore the forefront of pain management with a glimpse into emerging novel treatments, such as learning 2-3 therapies on the horizon for chronic non-cancer pain sufferers.

Faculty: Soraya Azari, MD | Joan Deng, MD, PhD Caitin Garvey, RN, MS, AGPCNP-bc

PRICE: $275 (Members) | $385 (Non-Members)

Target Audience

This activity is designed for health care professionals that want to know more about the latest in treating patients with opioid substance use disorder, the state of current systems of care, and the legal implications of staying in compliance.

Learning Objectives

After participating in this workshop, the registrants should be able to:

  • Define the relationship between pain and addiction and explain how chronic opioid therapy can lead to addiction.
  • Review the best practices in pain management for individuals with a history of a substance use disorder.  
  • Assess the role of the healthcare system and policy makers in addressing pain management and addiction, including prescribing guidelines, education, and intervention strategies.
  • Develop a treatment plan for patients with chronic pain and addiction, including the integration of pharmacological, behavioral, and alternative therapies.
  • Demonstrate effective communication and counseling skills in working with patients with pain and addiction, including motivational interviewing and empathic listening.
     
    Course summary
    Available credit: 
    • 3.00 AMA Category 1
    • 3.00 Attendance
    Course opens: 
    10/08/2024
    Course expires: 
    10/02/2026
    Cost:
    $385.00

    Soraya Azari, MD | Joan Deng, MD, PhD Caitin Garvey, RN, MS, AGPCNP-bc

     

    PHYSICIANS: The California Society of Addiction Medicine (CSAM) is accredited by the California Medical Association to provide continuing medical education for physicians.  CSAM takes responsibility for the content, quality and scientific integrity of this CME activity.

    CSAM designates this educational activity/enduring material for a maximum of 3 AMA/PRA Category 1 Credits™. (Physicians should only claim credit commensurate with the extent of their participation in the activity.) This credit may also be applied to the CMA Certification in Continuing Medical Education.

    NON-PHYSICIANS: The California Society of Addiction Medicine (CSAM) provides a certificate of attendance for this online course based upon the number of hours you participated, up to maximum of 3. 

    DISCLOSURE OF FINANCIAL RELATIONSHIPS

    In accordance with the ACCME Standards for Integrity and Independence, CSAM adheres to guidelines and processes to identify and mitigate relevant financial relationships for all individuals in a position to control the content of this activity. Unless otherwise noted, faculty did not have any relevant financial relationships with ineligible companies, as defined by ACCME, within the past 24 months. All relevant financial relationships have been mitigated.

    Available Credit

    • 3.00 AMA Category 1
    • 3.00 Attendance

    Price

    Cost:
    $385.00
    Please login or register to take this course.